Search results
Bernie Sanders to grill Novo Nordisk CEO on why weight-loss drugs Ozempic and Wegovy can cost up to...
INSIDER via Yahoo News· 2 days agoNordisk will testify on the high cost of the weight-loss drugs Ozempic and Wegovy. Lars Jørgensen...
Drugmaker to testify on why weight-loss drugs cost 15x more in the US
Ars Technica· 7 hours agoReading“Outrageously” priced weight-loss drugs could bankrupt US health careCEO Lars Jørgensen will...
Senate committee to vote on subpoena for Novo Nordisk executive
The Hill via Yahoo News· 6 days agoSen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) ...
Sen. Sanders calls off subpoena vote over maker of Ozempic and Wegovy
BenefitsPRO· 3 days agoSanders, the chairman of the Senate Health, Education, Labor andPensions Committee, had announced...
Offering workers both DB & DC retirement plan options: The best of both worlds?
BenefitsPRO· 3 days agopension. The NIRS report was prompted by recent developments in Congress—specifically, a request for...
Biden wins endorsements from three seniors groups
Reuters via Yahoo News· 6 days agoThe National Committee to Preserve Social Security & Medicare (NCPSSM), which defied a 38-year... PAC and the bipartisan National United Committee to...
Bernie Sanders will grill Novo Nordisk's CEO over Ozempic and Wegovy prices
Quartz· 12 hours agoCEO Lars Fruergaard Jørgensen will testify before the Senate's health committee after Sanders...
Sen. Sanders calls for Novo Nordisk subpoena over Wegovy and Ozempic pricing
BenefitsPRO· 5 days agoSanders, a Vermont independent, is the chairman of the Senate Health, Education, Labor and Pensions ...
Sanders drops subpoena effort after Novo Nordisk CEO agrees to testify
The Hill· 3 days agoThe vote that was scheduled for next week was preempted with the announcement that Novo Nordisk CEO...
Sanders calls vote to subpoena Novo Nordisk president
Becker’s Hospital Review· 7 days agoBernie Sanders and Novo Nordisk, the Senate Committee on Health, Education, Labor, and Pensions will vote June 18 on whether to subpoena the drugmaker's ...